rvsp and pulmonary hypertension

Pulmonary Hypertension (PH) is a type of cardiovascular disease characterized primarily by increased Pulmonary Vascular Resistance (PVR). This condition can lead to an increased workload on the right ventricle, potentially resulting in right-sided heart failure. Typically, individuals with PH exhibit PVR levels significantly higher than the normal range, which can severely impact their health.

The normal range for PVR is between 1 and 2.5 Wood Units (WU) per square meter of body surface area. When PVR surpasses this range, symptoms such as shortness of breath, fatigue, and chest pain may emerge. As the disease advances, these symptoms can intensify, impairing the patient's daily quality of life. In some instances, PH can be life-threatening.

For patients diagnosed with PH, it is imperative to seek medical care promptly and receive specialized treatment. Treatment options may encompass pharmacotherapy, oxygen therapy, and surgical interventions. Patients should also focus on lifestyle modifications, including quitting smoking, restricting salt intake, and engaging in appropriate physical activities. Furthermore, regular monitoring of disease progression and adjustment of treatment plans are crucial. In conclusion, when confronting the serious illness of PH, patients should actively collaborate with their healthcare providers and vigilantly monitor their health status.